MATTHEW M LOAR Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MATTHEW M LOAR.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MATTHEW M LOAR. MATTHEW M LOAR is a CFO in GENELABS TECHNOLOGIES INC /CA ($GNLB) and a Chief Financial Officer in OXIGENE INC ($OXGN).

Companies in which MATTHEW M LOAR is an Insider

GENELABS TECHNOLOGIES INC /CA

Trading Symbol: GNLB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW M LOAR: CFO
Holdings: 5,000 shares
Latest Transaction: Jan 26 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Oncotelic Therapeutics, Inc.

Trading Symbol: MATN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW M LOAR: Chief Financial Officer
Holdings: 300,000 shares
Latest Transaction: Jun 22 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of MATTHEW M LOAR

Sentiment: All, GNLB, MATN

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 22 2018OXGNMATEON THERAPEUTIC ...LOAR MATTHEW MChief Financial Off ...Option ExerciseA0.22500,000110,000500,000
Jun 22 2018OXGNMATEON THERAPEUTIC ...LOAR MATTHEW MChief Financial Off ...Option ExerciseA0.22250,00055,000250,000
Apr 16 2018OXGNMATEON THERAPEUTIC ...LOAR MATTHEW MChief Financial Off ...Option ExerciseP0.40125,00050,000125,000
Apr 16 2018OXGNMATEON THERAPEUTIC ...LOAR MATTHEW MChief Financial Off ...Option ExerciseP0.40125,00050,000125,000
Apr 16 2018OXGNMATEON THERAPEUTIC ...LOAR MATTHEW MChief Financial Off ...BuyP0.00250,0000300,00050 K to 300 K (+500.00 %)
Jan 13 2017OXGNMATEON THERAPEUTIC ...LOAR MATTHEW MChief Financial Off ...Option ExerciseA0.38350,000131,250350,000
Mar 23 2016OXGNOXIGENE INCLOAR MATTHEW MChief Financial Off ...Option ExerciseA0.73262,500191,021262,500

View all MATTHEW M LOAR insider transactions.